Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity

Curative therapeutic options for a number of immunological disorders remain to be established, and approaches for identifying drug candidates are relatively limited. Furthermore, phenotypic screening methods using induced pluripotent stem cell (iPSC)-derived immune cells or hematopoietic cells need...

Descripción completa

Detalles Bibliográficos
Autores principales: Seki, Ryosuke, Ohta, Akira, Niwa, Akira, Sugimine, Yoshinori, Naito, Haruna, Nakahata, Tatsutoshi, Saito, Megumu K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437452/
https://www.ncbi.nlm.nih.gov/pubmed/32810141
http://dx.doi.org/10.1371/journal.pone.0237030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437452/
https://www.ncbi.nlm.nih.gov/pubmed/32810141
http://dx.doi.org/10.1371/journal.pone.0237030

Ejemplares similares